Objectives: To examine the relationship between indicators of inflammation and the incidence of mobility limitation in older persons. Design: Prospective cohort study: the Health, Aging and Body Composition Study. Setting: Pittsburgh, Pennsylvania, and Memphis, Tennessee. Participants: A total of 2,979 men and women, aged 70 to 79, without mobility limitation at baseline. Measurements: Serum levels of interleukin (IL)‐6, tumor necrosis factor alpha (TNFα), and C‐reactive protein (CRP) and soluble cytokine receptors (IL‐2sR, IL‐6sR, TNFsR1, TNFsR2) were measured. Mobility limitation was assessed and defined as reporting difficulty or inability to walk one‐quarter of a mile or to climb 10 steps during two consecutive semiannual assessments over 30 months. Results: Of the 2,979 participants, 30.1% developed incident mobility limitation. After adjustment for confounders (demographics, prevalent conditions at baseline, body composition), the relative risk (RR) of incident mobility limitation per standard deviation (SD) increase was 1.19 (95% confidence interval (CI)=1.10–1.28) for IL‐6, 1.20 (95% CI=1.12–1.29) for TNFα, and 1.40 (95% CI=1.18–1.68) for CRP. The association between inflammation and incident mobility limitation was especially strong for the onset of more severe mobility limitation and when the levels of multiple inflammatory markers were high. When persons with baseline or incident cardiovascular disease events or persons who were hospitalized during study follow‐up were excluded, findings remained similar. In a subset (n=499), high levels of the soluble receptors IL2sR and TNFsR1 (per SD increase: RR=1.23 (95% CI=1.04–1.46) and RR=1.28 (95% CI=1.04–1.57), respectively) were also associated with incident mobility limitation. Conclusion: Findings suggest that inflammation is prognostic for incident mobility limitation over 30 months, independent of cardiovascular disease events and incident severe illness.
Journal of American Geriatrics Society – Wiley
Published: Jul 1, 2004
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera